|
US4713249A
(en)
|
1981-11-12 |
1987-12-15 |
Schroeder Ulf |
Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
|
|
DE116208T1
(de)
|
1982-12-07 |
1985-02-28 |
Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo |
Mitomycin-analoge.
|
|
JPS60255789A
(ja)
|
1984-06-01 |
1985-12-17 |
Kyowa Hakko Kogyo Co Ltd |
マイトマイシン誘導体，その製造法および抗腫瘍剤
|
|
US5266333A
(en)
|
1985-03-06 |
1993-11-30 |
American Cyanamid Company |
Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
|
|
US5103018A
(en)
|
1986-08-26 |
1992-04-07 |
Kyowa Hakko Kogyo Kabushiki Kaisha |
Mitomycin derivatives
|
|
USH806H
(en)
|
1987-07-16 |
1990-08-07 |
Fmc Corporation |
Herbicidal clomazone compositions and methods of use tolerant to corn and other crops
|
|
KR910009284A
(ko)
|
1989-11-13 |
1991-06-28 |
원본미기재 |
인체 종양 세포 항원에 특이적인 키메라형 생쥐-인체 a10 항체
|
|
US5627165A
(en)
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
|
AU653565B2
(en)
|
1990-12-21 |
1994-10-06 |
Nikken Corporation |
Raw sewage disposal apparatus and prefab for accomodating the same
|
|
US6342491B1
(en)
|
1991-05-21 |
2002-01-29 |
American Home Products Corporation |
Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin
|
|
US6291196B1
(en)
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US5674977A
(en)
|
1993-02-05 |
1997-10-07 |
The Ontario Cancer Institute |
Branched synthetic peptide conjugate
|
|
GB9314623D0
(en)
|
1993-07-14 |
1993-08-25 |
Nordion Int Inc |
Localization and therapy with agents directed against prostate specific antigen in breast cancer
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
JP3538221B2
(ja)
|
1993-11-19 |
2004-06-14 |
富士写真フイルム株式会社 |
定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法
|
|
US5417982A
(en)
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
|
US5866679A
(en)
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
|
GB9417873D0
(en)
*
|
1994-09-06 |
1994-10-26 |
Sandoz Ltd |
Organic compounds
|
|
US6946133B1
(en)
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
PT907379E
(pt)
|
1996-04-01 |
2004-09-30 |
Epix Medical Inc |
Agentes de contraste bioactivados para imagiologia de diagnostico
|
|
US5962237A
(en)
|
1996-04-05 |
1999-10-05 |
The Johns Hopkins University School Of Medicine |
Method of enriching rare cells
|
|
US5795877A
(en)
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
|
US5902817A
(en)
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
|
US6054444A
(en)
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
|
US5863536A
(en)
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
|
US5672592A
(en)
|
1996-06-17 |
1997-09-30 |
Guilford Pharmaceuticals Inc. |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
|
|
US5998362A
(en)
|
1996-09-12 |
1999-12-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US5962521A
(en)
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
|
US6177404B1
(en)
|
1996-10-15 |
2001-01-23 |
Merck & Co., Inc. |
Conjugates useful in the treatment of benign prostatic hyperplasia
|
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6548260B1
(en)
|
1997-01-21 |
2003-04-15 |
Bayer Corporation |
Detection of PSA-α2-macroglobulin complex in a biological fluid
|
|
AU7019498A
(en)
|
1997-04-10 |
1998-10-30 |
Diagnocure Inc. |
Pca3, pca3 genes, and methods of use
|
|
US6504014B1
(en)
|
1997-05-19 |
2003-01-07 |
The John Hopkins University |
Tissue specific prodrug
|
|
AU7582298A
(en)
|
1997-05-19 |
1998-12-11 |
Johns Hopkins University School Of Medicine, The |
Tissue specific prodrug
|
|
US6127333A
(en)
|
1997-07-10 |
2000-10-03 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US20020115596A1
(en)
|
1997-10-27 |
2002-08-22 |
Merk & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
ZA9810974B
(en)
|
1997-12-02 |
1999-06-03 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
|
ID24735A
(id)
|
1997-12-02 |
2000-08-03 |
Merck & Co Ltd |
Konjugat-konjugat yang berguna pada pengobatan kanker prostat
|
|
US20040081659A1
(en)
|
1997-12-02 |
2004-04-29 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
AU2896399A
(en)
|
1998-03-03 |
1999-09-20 |
Exact Sciences Corporation |
Purification and detection processes using reversible affinity electrophoresis
|
|
US20020103136A1
(en)
|
1998-03-05 |
2002-08-01 |
Dong-Mei Feng |
Conjugates useful in the treatment of prostate cancer
|
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
|
FR2778820B1
(fr)
|
1998-05-20 |
2000-07-28 |
Rhone Poulenc Agrochimie |
Melanges herbicides a base d'aclonifen et de clomazone
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
DE69941187D1
(de)
|
1998-06-01 |
2009-09-10 |
Agensys Inc |
Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
|
|
US6518033B1
(en)
|
1998-08-05 |
2003-02-11 |
The Research Foundation Of State University Of New York |
Method of detecting the presence of CD155 for diagnosis of cancer and to determine treatment
|
|
US20070020327A1
(en)
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
|
US6174858B1
(en)
|
1998-11-17 |
2001-01-16 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6602274B1
(en)
|
1999-01-15 |
2003-08-05 |
Light Sciences Corporation |
Targeted transcutaneous cancer therapy
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
AU4063600A
(en)
|
1999-04-05 |
2000-10-23 |
Merck & Co., Inc. |
A method of treating cancer
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
CA2367787C
(en)
|
1999-04-28 |
2011-07-26 |
Alan P. Kozikowski |
Ligands for metabotropic glutamate receptors
|
|
AUPQ014799A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using polymers
|
|
US7166573B1
(en)
|
1999-05-28 |
2007-01-23 |
Ludwig Institute For Cancer Research |
Breast, gastric and prostate cancer associated antigens and uses therefor
|
|
US20040146516A1
(en)
|
1999-06-17 |
2004-07-29 |
Utah Ventures Ii L.P. |
Lumen-exposed molecules and methods for targeted delivery
|
|
PL354186A1
(en)
|
1999-07-13 |
2003-12-29 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, asTHE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH AND HUMAN SERVICES |
T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof
|
|
WO2001008636A2
(en)
|
1999-08-03 |
2001-02-08 |
The Ohio State University |
Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
|
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
CA2387901A1
(en)
|
1999-10-27 |
2001-05-03 |
Merck & Co., Inc. |
Salt form of a conjugate useful in the treatment of prostate cancer
|
|
US6428785B1
(en)
|
1999-10-28 |
2002-08-06 |
Immunolytics Inc. |
Method and composition for treating prostate cancer
|
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
CA2391534A1
(en)
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Selective cellular targeting: multifunctional delivery vehicles
|
|
AU5697001A
(en)
|
2000-03-31 |
2001-10-15 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
JP4176466B2
(ja)
|
2000-10-16 |
2008-11-05 |
ギリード・サイエンシズ・インコーポレーテッド |
前立腺特異的膜抗原に対する核酸リガンド
|
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US7468354B2
(en)
|
2000-12-01 |
2008-12-23 |
Genspera, Inc. |
Tissue specific prodrugs
|
|
EP1390081A2
(en)
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutic and diagnostic compounds, compositions, and methods
|
|
DE60214134T2
(de)
|
2001-02-07 |
2007-07-19 |
Beth Israel Deaconess Medical Center, Boston |
Modifizierte psma-liganden und deren verwendung
|
|
WO2002074345A2
(en)
|
2001-03-16 |
2002-09-26 |
Johns Hopkins University School Of Medicine |
Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
|
|
CN100351255C
(zh)
|
2001-03-21 |
2007-11-28 |
L.摩尔特尼公司和阿立提兄弟贸易公司股份公司 |
金属取代的非中心对称型酞菁类似物,其制备方法以及在光动力治疗和体内诊断中的用途
|
|
JP4206272B2
(ja)
|
2001-03-29 |
2009-01-07 |
サイナージィ ファーマスーティカルズ、インコーポレイテッド |
組織炎症及び発癌を治療するためのグアニル酸シクラーゼ受容体アゴニスト
|
|
US7875612B2
(en)
|
2001-04-24 |
2011-01-25 |
Purdue Research Foundation |
Folate mimetics and folate-receptor binding conjugates thereof
|
|
RU2316349C2
(ru)
|
2001-05-02 |
2008-02-10 |
Пердью Рисерч Фаундейшн |
Лечение и диагностика заболеваний, опосредованных макрофагами
|
|
US20040092890A1
(en)
|
2001-05-10 |
2004-05-13 |
Ash Stephen R. |
Catheter lock solution including a photo-oxidant
|
|
US7109165B2
(en)
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
US7666414B2
(en)
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US20040018203A1
(en)
|
2001-06-08 |
2004-01-29 |
Ira Pastan |
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
|
|
AU2002315411A1
(en)
|
2001-06-21 |
2003-01-08 |
Glycotech Corporation |
Detection and treatment of prostate cancer
|
|
WO2003000201A2
(en)
|
2001-06-25 |
2003-01-03 |
Drug Innovation & Design, Incorporated |
Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications
|
|
US7755757B2
(en)
|
2007-02-14 |
2010-07-13 |
Chemimage Corporation |
Distinguishing between renal oncocytoma and chromophobe renal cell carcinoma using raman molecular imaging
|
|
US6596755B2
(en)
|
2001-07-02 |
2003-07-22 |
Dabur Research Foundation |
Oral formulation of methylglyoxal and its imino acid conjugates for human use
|
|
US6613793B2
(en)
|
2001-07-02 |
2003-09-02 |
Dabur Research Foundation |
Anticancer activity of imino acid conjugates or methylglyoxal
|
|
US7893223B2
(en)
|
2001-07-17 |
2011-02-22 |
Bracco Imaging S.P.A. |
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
|
|
US7282476B2
(en)
|
2001-08-24 |
2007-10-16 |
University Of Victoria Innovation And Development Corporation |
Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
|
|
US20030049203A1
(en)
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
US7192586B2
(en)
|
2001-09-20 |
2007-03-20 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
|
|
US20030232760A1
(en)
|
2001-09-21 |
2003-12-18 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
EP1434603B1
(en)
|
2001-09-28 |
2009-12-16 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
US20030215456A1
(en)
|
2001-10-02 |
2003-11-20 |
Sui-Long Yao |
Method of treating cancer
|
|
US20030133927A1
(en)
|
2001-10-10 |
2003-07-17 |
Defeo-Jones Deborah |
Conjugates useful in the treatment of prostate cancer
|
|
US20040058857A1
(en)
|
2001-11-29 |
2004-03-25 |
Siu-Long Yao |
Method of treating cancer
|
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
AU2002364202A1
(en)
|
2001-12-21 |
2003-07-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt |
Novel metastasis suppressor gene on human chromosome 8
|
|
CA2473289C
(en)
|
2002-01-10 |
2014-07-29 |
The Johns Hopkins University |
Asymmetric urea compounds useful as naaladase and psma imaging agents
|
|
CA2474728A1
(en)
|
2002-02-06 |
2003-08-14 |
Johns Hopkins University School Of Medicine |
Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
|
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
|
US8491896B2
(en)
|
2002-06-14 |
2013-07-23 |
Immunomedics, Inc. |
Anti-pancreatic cancer antibodies
|
|
US7344700B2
(en)
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
US9745380B2
(en)
|
2002-03-01 |
2017-08-29 |
Immunomedics, Inc. |
RS7 antibodies
|
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
|
US20170281791A1
(en)
|
2002-03-01 |
2017-10-05 |
Immunomedics, Inc. |
Anti-trop-2 antibody-drug conjugates and uses thereof
|
|
EP1483295B1
(en)
|
2002-03-01 |
2008-12-10 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
US7794929B2
(en)
|
2002-03-07 |
2010-09-14 |
The Johns Hopkins University School Of Medicine |
Genomic screen for epigenetically silenced genes associated with cancer
|
|
US7534580B2
(en)
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
|
WO2003092742A1
(en)
|
2002-05-06 |
2003-11-13 |
Endocyte, Inc. |
Vitamin-targeted imaging agents
|
|
DE60326833D1
(de)
|
2002-05-15 |
2009-05-07 |
Endocyte Inc |
Vitamin-mitomycin-konjugate
|
|
CN1675245B
(zh)
|
2002-06-14 |
2011-01-12 |
免疫医疗公司 |
人源化单克隆抗体hPAM4
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
JP4741838B2
(ja)
|
2002-07-31 |
2011-08-10 |
シアトル ジェネティクス，インコーポレーテッド |
癌、自己免疫疾患または感染症を治療するための薬物結合体およびその使用
|
|
AR040956A1
(es)
|
2002-07-31 |
2005-04-27 |
Schering Ag |
Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
|
|
US7749968B2
(en)
|
2002-08-05 |
2010-07-06 |
The Johns Hopkins University |
Peptides for targeting the prostate specific membrane antigen
|
|
WO2004015086A2
(en)
|
2002-08-08 |
2004-02-19 |
Johns Hopkins University |
Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
|
|
US8487128B2
(en)
|
2002-11-26 |
2013-07-16 |
Chs Pharma, Inc. |
Protection of normal cells
|
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
|
JP4959136B2
(ja)
|
2002-12-13 |
2012-06-20 |
イミューノメディクス、インコーポレイテッド |
細胞内で開裂可能な結合を有する免疫接合体
|
|
WO2004058158A2
(en)
|
2002-12-20 |
2004-07-15 |
The Johns Hopkins University |
Treatment of metastatic cancer with the b-subunit of shiga toxin
|
|
US7166691B2
(en)
|
2002-12-20 |
2007-01-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Saposin C and receptors as targets for treatment of benign and malignant disorders
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
US20080008649A1
(en)
*
|
2003-01-13 |
2008-01-10 |
Bracco Imaging S.P.A. |
Gastrin Releasing Peptide Compounds
|
|
AR042942A1
(es)
|
2003-01-27 |
2005-07-06 |
Endocyte Inc |
Conjugados de administracion de drogas de union de receptores de vitaminas
|
|
US7811564B2
(en)
|
2003-01-28 |
2010-10-12 |
Proscan Rx Pharma |
Prostate cancer diagnosis and treatment
|
|
EP1444990A1
(en)
|
2003-02-07 |
2004-08-11 |
Amersham plc |
Improved Radiometal Complex Compositions
|
|
WO2004072080A1
(en)
|
2003-02-10 |
2004-08-26 |
Cellular Genomics, Inc. |
Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
|
|
WO2004080412A2
(en)
|
2003-03-07 |
2004-09-23 |
The University Of Toledo |
Paclitaxel hybrid derivatives
|
|
US7638122B2
(en)
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
US20070179100A1
(en)
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
|
CA2522637C
(en)
|
2003-04-17 |
2014-01-21 |
Alnylam Pharmaceuticals, Inc. |
Modified irna agents
|
|
EP1641742A4
(en)
|
2003-05-01 |
2006-11-29 |
Nst Neurosurvival Technologies |
COMPOUNDS BINDING SELECTIVELY TO MEMBRANES OF APOPTOTIC CELLS
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
US7172751B2
(en)
|
2003-06-13 |
2007-02-06 |
Immunomedics, Inc. |
D-amino acid peptides
|
|
US7232805B2
(en)
|
2003-09-10 |
2007-06-19 |
Inflabloc Pharmaceuticals, Inc. |
Cobalamin conjugates for anti-tumor therapy
|
|
US20050255042A1
(en)
|
2003-11-24 |
2005-11-17 |
The Regents Of The University Of California Office Of Technology Transfer, University Of California |
On-demand cleavable linkers for radioconjugates for cancer imaging and therapy
|
|
FR2864546A1
(fr)
|
2003-12-24 |
2005-07-01 |
Assist Publ Hopitaux De Paris |
Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
|
|
ATE437184T1
(de)
|
2004-01-12 |
2009-08-15 |
Applied Molecular Evolution |
Varianten der fc-region
|
|
WO2006051531A2
(en)
|
2004-11-09 |
2006-05-18 |
Spectrum Dynamics Llc |
Radioimaging
|
|
WO2007010534A2
(en)
|
2005-07-19 |
2007-01-25 |
Spectrum Dynamics Llc |
Imaging protocols
|
|
US8586932B2
(en)
|
2004-11-09 |
2013-11-19 |
Spectrum Dynamics Llc |
System and method for radioactive emission measurement
|
|
DE102004004787A1
(de)
|
2004-01-30 |
2005-08-18 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
|
AU2005216251B2
(en)
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
CN1926433A
(zh)
|
2004-03-03 |
2007-03-07 |
拜奥默里克斯公司 |
用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途
|
|
WO2005094882A1
(en)
|
2004-03-03 |
2005-10-13 |
Millennium Pharmaceuticals, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
DE602005008497D1
(de)
|
2004-03-15 |
2008-09-11 |
Roche Diagnostics Gmbh |
Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung
|
|
US20060105975A1
(en)
|
2004-04-19 |
2006-05-18 |
Shannon Pendergrast |
Aptamer-mediated intracellular delivery of therapeutic oligonucleotides
|
|
US7910693B2
(en)
|
2004-04-19 |
2011-03-22 |
Proscan Rx Pharma Inc. |
Prostate cancer diagnosis and treatment
|
|
WO2005112919A2
(en)
|
2004-05-19 |
2005-12-01 |
Medarex, Inc. |
Self-immolative linkers and drug conjugates
|
|
US7691962B2
(en)
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
|
CN101098854B
(zh)
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
US20060148741A1
(en)
|
2004-07-26 |
2006-07-06 |
Government Of The Usa, Represented By The Secretary, Department Of Health And Human Services |
Metastasis suppressor gene on human chromosome 8 and its use in the diagnosis, prognosis and treatment of cancer
|
|
DK2213683T3
(da)
|
2004-08-04 |
2013-09-02 |
Mentrik Biotech Llc |
VARIANT-Fc-REGIONER
|
|
US20060045883A1
(en)
|
2004-08-26 |
2006-03-02 |
Jeffrey Molldrem |
Anti-cancer vaccines
|
|
KR20070063526A
(ko)
|
2004-08-30 |
2007-06-19 |
뉴로메드 파머큐티칼즈 리미티드 |
칼슘 채널 차단제인 우레아 유도체
|
|
US8194660B2
(en)
|
2004-09-09 |
2012-06-05 |
Amx Llc |
System, method, and computer-readable medium for dynamic device discovery for servers binding to multiple masters
|
|
US7713944B2
(en)
|
2004-10-13 |
2010-05-11 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
|
|
US7638525B2
(en)
|
2004-10-27 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Trisubstituted thiophenes as progesterone receptor modulators
|
|
US8423125B2
(en)
|
2004-11-09 |
2013-04-16 |
Spectrum Dynamics Llc |
Radioimaging
|
|
US20060140871A1
(en)
|
2004-11-30 |
2006-06-29 |
Sillerud Laurel O |
Magnetic resonance imaging of prostate cancer
|
|
US20060155021A1
(en)
|
2005-01-13 |
2006-07-13 |
Lenges Christian P |
Coating compositions containing rheology control agents
|
|
US7872235B2
(en)
|
2005-01-13 |
2011-01-18 |
Spectrum Dynamics Llc |
Multi-dimensional image reconstruction and analysis for expert-system diagnosis
|
|
US7741510B2
(en)
|
2005-01-13 |
2010-06-22 |
E. I. Du Pont De Nemours And Company |
Rheology control agents
|
|
EP1846576A4
(en)
|
2005-02-01 |
2009-01-07 |
Us Gov Health & Human Serv |
BIOMARKERS OF TISSUE STATUS
|
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
|
WO2006096754A2
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
KR101068612B1
(ko)
|
2005-05-24 |
2011-09-30 |
휴마시스 주식회사 |
유사구조 단백질 비율 측정을 이용한 진단장치
|
|
US8916161B2
(en)
|
2005-06-14 |
2014-12-23 |
Sophiris Bio Inc. |
Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
|
|
PT1912677E
(pt)
|
2005-06-20 |
2013-12-23 |
Psma Dev Company L L C |
Conjugados de anticorpos contra psma-fármaco
|
|
WO2007006041A2
(en)
|
2005-07-05 |
2007-01-11 |
Purdue Research Foundation |
Imaging and therapeutic method using monocytes
|
|
US20070010014A1
(en)
|
2005-07-06 |
2007-01-11 |
General Electric Company |
Compositions and methods for enhanced delivery to target sites
|
|
JP2009504786A
(ja)
|
2005-08-19 |
2009-02-05 |
シーラス コーポレイション |
リステリア属誘導型免疫漸増および活性化、ならびにその使用方法
|
|
EP2374480A3
(en)
|
2005-08-19 |
2013-05-01 |
Endocyte, Inc. |
Mutli-drug ligand conjugates
|
|
WO2007022493A2
(en)
|
2005-08-19 |
2007-02-22 |
Endocyte, Inc. |
Ligand conjugates of vinca alkaloids, analogs, and derivatives
|
|
EP2015781A4
(en)
|
2005-09-12 |
2009-12-23 |
Univ Johns Hopkins |
COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF
|
|
JP5368099B2
(ja)
|
2005-10-07 |
2013-12-18 |
ゲルベ |
ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物
|
|
CA2670355A1
(en)
|
2005-11-21 |
2008-04-24 |
Medivas, Llc |
Polymer particles for delivery of macromolecules and methods of use
|
|
DK2963011T3
(en)
|
2005-11-23 |
2018-08-06 |
Ventana Med Syst Inc |
MOLECULAR CONJUGATE
|
|
US8258256B2
(en)
|
2006-01-05 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
US20100047170A1
(en)
|
2006-01-05 |
2010-02-25 |
Denmeade Samuel R |
Peptide Prodrugs
|
|
US7635682B2
(en)
|
2006-01-06 |
2009-12-22 |
Genspera, Inc. |
Tumor activated prodrugs
|
|
JP2009525048A
(ja)
|
2006-02-01 |
2009-07-09 |
ザ ジョンズ ホプキンス ユニバーシティー |
腫瘍性障害または感染症に対する免疫学的予防法または免疫療法のためのポリペプチド−核酸複合体
|
|
PL1999136T3
(pl)
|
2006-03-14 |
2013-03-29 |
Cancer Targeted Tech Llc |
Peptydomimetyczne inhibitory PSMA, związki je zawierające i sposoby ich zastosowania
|
|
CA2646329C
(en)
|
2006-03-20 |
2018-07-03 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
US20140314864A1
(en)
|
2006-03-31 |
2014-10-23 |
Massachusetts Institute Of Technology |
System for Targeted Delivery of Therapeutic Agents
|
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
|
US7842280B2
(en)
|
2006-09-06 |
2010-11-30 |
Case Western Reserve University |
Flexibly labeling peptides
|
|
EP2087337A4
(en)
|
2006-11-03 |
2010-09-08 |
Purdue Research Foundation |
METHOD AND DEVICE FOR EX-VIVO FLOW CYTOMETRY
|
|
PT2097111E
(pt)
|
2006-11-08 |
2015-11-03 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutámico
|
|
WO2008079569A2
(en)
|
2006-11-21 |
2008-07-03 |
The Johns Hopkins University |
System and method for determining amount of radioactive material to administer to a patient
|
|
AU2007328207A1
(en)
|
2006-12-05 |
2008-06-12 |
Landec Corporation |
Drug delivery
|
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
CA2675202C
(en)
|
2007-01-11 |
2014-09-16 |
Immunomedics, Inc. |
Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
|
|
WO2008094254A2
(en)
|
2007-01-26 |
2008-08-07 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
|
CA2677792C
(en)
|
2007-02-07 |
2015-04-14 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
NZ599239A
(en)
|
2007-03-14 |
2013-10-25 |
Endocyte Inc |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
JP2010524856A
(ja)
|
2007-04-10 |
2010-07-22 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
ウイルス関連腫瘍の画像化および治療
|
|
US9138484B2
(en)
|
2007-06-25 |
2015-09-22 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
CA2694266C
(en)
|
2007-06-26 |
2016-06-14 |
The Johns Hopkins University |
Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents
|
|
GB0723246D0
(en)
|
2007-07-03 |
2008-01-09 |
Barton Michelle |
p53 modulator
|
|
JP2010533649A
(ja)
|
2007-07-13 |
2010-10-28 |
ザ ジョンズ ホプキンス ユニバーシティー |
Ｂ７−ｄｃ改変体
|
|
KR20100063048A
(ko)
|
2007-07-31 |
2010-06-10 |
더 존스 홉킨스 유니버시티 |
신생물성 또는 감염성 장애의 면역예방 또는 면역치료를 위한 폴리펩티드-핵산 접합체
|
|
EP2183382A1
(en)
|
2007-08-08 |
2010-05-12 |
Chemimage Corporation |
Raman difference spectra based disease classification
|
|
PL2187965T3
(pl)
|
2007-08-17 |
2020-05-18 |
Purdue Research Foundation |
Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania
|
|
US8865875B2
(en)
|
2007-08-22 |
2014-10-21 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions
|
|
US9585957B2
(en)
|
2007-09-07 |
2017-03-07 |
The Johns Hopkins University |
Adenosine receptor agonists and antagonists to modulate T cell responses
|
|
JP5410434B2
(ja)
|
2007-09-28 |
2014-02-05 |
バインド セラピューティックス インコーポレイテッド |
ナノ粒子を用いた癌細胞の標的化
|
|
US9187521B2
(en)
|
2007-10-25 |
2015-11-17 |
Endocyte, Inc. |
Tubulysins and processes for preparing
|
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
|
WO2009070302A1
(en)
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
|
EP2231194B1
(en)
|
2007-12-04 |
2017-02-22 |
Alnylam Pharmaceuticals Inc. |
Folate-irna conjugates
|
|
US20090180951A1
(en)
|
2007-12-12 |
2009-07-16 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
|
BRPI0906797A2
(pt)
|
2008-01-09 |
2015-07-14 |
Molecular Insight Pharm Inc |
Inibidores de anidrase carbônica ix
|
|
US8565945B2
(en)
|
2008-01-17 |
2013-10-22 |
Lockheed Martin Corporation |
Method for managing vital train movements
|
|
EP2259836A2
(en)
|
2008-04-04 |
2010-12-15 |
Molecular Insight Pharmaceuticals, Inc. |
Radiolabeled treatment infusion system, apparatus, and methods of using the same
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
EP2990487A1
(en)
|
2008-05-08 |
2016-03-02 |
Asuragen, INC. |
Compositions and methods related to mirna modulation of neovascularization or angiogenesis
|
|
DK2291659T3
(en)
|
2008-05-13 |
2015-12-21 |
Univ Yale |
SMALL CHEMICAL MOLECULES FOR RECRUITING ANTIBODIES TO CANCER CELLS
|
|
US8852630B2
(en)
|
2008-05-13 |
2014-10-07 |
Yale University |
Chimeric small molecules for the recruitment of antibodies to cancer cells
|
|
DK2774608T3
(da)
|
2008-06-16 |
2020-01-13 |
Pfizer |
Lægemiddelladede polymere nanopartikler og fremgangsmåder til fremstilling og anvendelse deraf
|
|
JP2011526888A
(ja)
|
2008-07-01 |
2011-10-20 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
治療薬を標的送達するための経口速溶性薄膜
|
|
DK3222615T3
(da)
|
2008-08-01 |
2022-06-20 |
Univ Johns Hopkins |
Psma-bindende stoffer og anvendelser deraf
|
|
US8685937B2
(en)
|
2008-08-09 |
2014-04-01 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
|
WO2010027641A2
(en)
|
2008-08-15 |
2010-03-11 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
PL2326350T3
(pl)
|
2008-09-08 |
2014-03-31 |
Psma Dev Company L L C |
Związki do zabijania eksprymujących PSMA, opornych na taksan komórek rakowych
|
|
EP2166021A1
(en)
|
2008-09-16 |
2010-03-24 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies for treatment of cancer
|
|
AU2009293140A1
(en)
|
2008-09-17 |
2010-03-25 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
US20110288152A1
(en)
|
2008-10-17 |
2011-11-24 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2010065899A2
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof
|
|
RU2539584C2
(ru)
|
2008-12-05 |
2015-01-20 |
Моликьюлар Инсайт Фармасьютикалз, Инк. |
Комплексы технеция и рения с бис(гетероарилами) и способы их применения
|
|
WO2010065906A2
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
|
|
EP3903829B1
(en)
|
2009-02-13 |
2023-05-03 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
US10517969B2
(en)
|
2009-02-17 |
2019-12-31 |
Cornell University |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
CA2754217A1
(en)
|
2009-03-02 |
2010-09-10 |
Massachusetts Institute Of Technology |
Methods and systems for treatment and/or diagnosis
|
|
US8772226B2
(en)
|
2009-03-17 |
2014-07-08 |
The Johns Hopkins University |
Methods and compositions for the detection of cancer
|
|
PL3964502T3
(pl)
|
2009-03-19 |
2024-10-28 |
The Johns Hopkins University |
Związki do kierunkowania w psma i ich zastosowania
|
|
US10717750B2
(en)
|
2009-03-19 |
2020-07-21 |
The Johns Hopkins University |
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
|
|
US9757084B2
(en)
|
2011-12-22 |
2017-09-12 |
The Johns Hopkins University |
Method and system for administering radiopharmaceutical therapy (RPT)
|
|
WO2010135313A1
(en)
|
2009-05-19 |
2010-11-25 |
Aic Blab Company |
Composite current collector and methods therefor
|
|
BR112012000209B8
(pt)
|
2009-06-15 |
2021-07-27 |
Molecular Insight Pharm Inc |
heterodímeros de ácido glutâmico e seus processos de preparação
|
|
WO2011014821A1
(en)
|
2009-07-31 |
2011-02-03 |
Endocyte, Inc. |
Folate-targeted diagnostics and treatment
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
US8685891B2
(en)
|
2009-08-27 |
2014-04-01 |
Nuclea Biotechnologies, Inc. |
Method and assay for determining FAS expression
|
|
EP2506876B1
(en)
|
2009-12-02 |
2016-10-12 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
|
MX338831B
(es)
|
2010-02-04 |
2016-05-03 |
Radius Health Inc |
Moduladores selectivos de receptores de androgenos.
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
US20120322741A1
(en)
|
2010-02-25 |
2012-12-20 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2011109422A2
(en)
|
2010-03-02 |
2011-09-09 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment of cancer
|
|
JP2010159277A
(ja)
|
2010-03-04 |
2010-07-22 |
Sumitomo Chemical Co Ltd |
有害生物防除組成物及び有害生物の防除方法
|
|
EP2371864A1
(en)
|
2010-03-23 |
2011-10-05 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies for treatment of cancer
|
|
US9006415B2
(en)
|
2010-04-06 |
2015-04-14 |
Massachusetts Institute Of Technology |
Targeted delivery of nucleic acids
|
|
HRP20130953T1
(hr)
|
2010-04-15 |
2013-11-22 |
Spirogen Sàrl |
Pirolobenzodiazepini i njihovi konjugati
|
|
WO2011140340A1
(en)
|
2010-05-05 |
2011-11-10 |
Safety Syringes, Inc. |
Needle based helical coil safety device
|
|
CN101863924B
(zh)
|
2010-05-17 |
2012-06-27 |
北京师范大学 |
99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法
|
|
EP2593098A4
(en)
|
2010-07-16 |
2014-02-05 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
|
|
US9029340B2
(en)
|
2010-07-22 |
2015-05-12 |
The Johns Hopkins University |
Radiation sensitization agents for prostate cancer
|
|
US9580474B2
(en)
|
2010-09-08 |
2017-02-28 |
The Johns Hopkins University |
Polyionic papilloma virus-like particle (VLP) vaccines
|
|
KR101236142B1
(ko)
|
2010-09-30 |
2013-02-21 |
경북대학교 산학협력단 |
가돌리늄 착물을 함유하는 ｍｒｉ조영제
|
|
WO2012078534A1
(en)
|
2010-12-06 |
2012-06-14 |
Molecular Insight Pharmaceuticals |
Psma-targeted dendrimers
|
|
EP2691120A4
(en)
|
2011-03-31 |
2014-09-24 |
Univ Johns Hopkins |
THEROSTATIC ILLUSTRATION AND USE METHOD THEREFOR
|
|
AU2012236068A1
(en)
|
2011-04-01 |
2013-10-17 |
Eureka Therapeutics, Inc. |
T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2
|
|
ES2541295T3
(es)
|
2011-04-21 |
2015-07-17 |
Orion Corporation |
Carboxamidas que modulan el receptor de andrógenos
|
|
US9180214B1
(en)
|
2011-04-22 |
2015-11-10 |
Stc.Unm |
Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer
|
|
WO2012154511A2
(en)
|
2011-05-06 |
2012-11-15 |
The Johns Hopkins University |
Method and device for statistical tissue sampling using microdevices
|
|
WO2012166923A2
(en)
|
2011-05-31 |
2012-12-06 |
Bind Biosciences |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
ES2657863T3
(es)
*
|
2011-06-15 |
2018-03-07 |
Cancer Targeted Technology Llc |
Inhibidores quelados de PSMA
|
|
PL2739316T3
(pl)
*
|
2011-08-05 |
2019-09-30 |
Molecular Insight Pharmaceuticals, Inc. |
Radioznakowane inhibitory antygenu błonowego specyficznego dla prostaty
|
|
WO2013028664A1
(en)
|
2011-08-22 |
2013-02-28 |
Siemens Medical Solutions Usa, Inc. |
Psma imaging agents
|
|
US9034318B2
(en)
|
2011-08-30 |
2015-05-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
|
|
WO2013060793A1
(en)
*
|
2011-10-25 |
2013-05-02 |
Technische Universität München |
Bifunctional ligands for radiometals
|
|
WO2013070457A2
(en)
|
2011-11-01 |
2013-05-16 |
The Johns Hopkins University |
Method and device for endoscopic abrasion
|
|
WO2013082338A1
(en)
|
2011-11-30 |
2013-06-06 |
The Johns Hopkins University |
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
|
|
CA2860504A1
(en)
|
2012-01-06 |
2013-07-11 |
Molecular Insight Pharmaceuticals |
Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase ix
|
|
US9629918B2
(en)
|
2012-02-29 |
2017-04-25 |
Purdue Research Foundation |
Folate receptor alpha binding ligands
|
|
US9498546B2
(en)
|
2012-03-14 |
2016-11-22 |
The Johns Hopkins University |
Synthesis and application of novel imaging agents conjugated to DPA 713 analogs for imaging inflammation
|
|
US9556167B2
(en)
|
2012-05-02 |
2017-01-31 |
Yale University |
TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
|
|
WO2013185052A1
(en)
|
2012-06-08 |
2013-12-12 |
Aduro Biotech |
Compostions and methods for cancer immunotherapy
|
|
EP3653733A1
(en)
|
2012-07-27 |
2020-05-20 |
Aragon Pharmaceuticals, Inc. |
Methods and compositions for determining resistance to androgen receptor therapy
|
|
US20140107316A1
(en)
|
2012-10-16 |
2014-04-17 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
US9662402B2
(en)
|
2012-10-16 |
2017-05-30 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
US20140113322A1
(en)
|
2012-10-22 |
2014-04-24 |
The Johns Hopkins University |
Supramolecular nanobeacon imaging agents as protease sensors
|
|
WO2014066002A1
(en)
|
2012-10-23 |
2014-05-01 |
The Johns Hopkins University |
Novel self-assembling drug amphiphiles and methods for synthesis and use
|
|
KR102575825B1
(ko)
|
2012-11-15 |
2023-09-06 |
엔도사이트, 인코포레이티드 |
Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트
|
|
US20140154702A1
(en)
|
2012-11-30 |
2014-06-05 |
Endocyte, Inc. |
Methods For Treating Cancer Using Combination Therapies
|
|
KR102002826B1
(ko)
|
2012-12-04 |
2019-07-23 |
삼성전자 주식회사 |
저장 장치, 플래시 메모리 및 저장 장치의 동작 방법
|
|
CN105246894A
(zh)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
US20140187501A1
(en)
|
2012-12-28 |
2014-07-03 |
Blend Therapeutics, Inc. |
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
|
|
SG11201505477TA
(en)
|
2013-01-14 |
2015-08-28 |
Molecular Insight Pharm Inc |
Triazine based radiopharmaceuticals and radioimaging agents
|
|
US10207005B2
(en)
|
2013-02-15 |
2019-02-19 |
Case Western Reserve University |
Photodynamic therapy composition
|
|
US9889199B2
(en)
|
2013-02-15 |
2018-02-13 |
Case Western Reserve University |
PSMA ligands and uses thereof
|
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
|
US9255262B2
(en)
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
US9567402B2
(en)
|
2013-03-14 |
2017-02-14 |
The Regents Of The University Of California |
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
|
|
US10434194B2
(en)
|
2013-06-20 |
2019-10-08 |
Case Western Reserve University |
PSMA targeted nanobubbles for diagnostic and therapeutic applications
|
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
JP5817799B2
(ja)
|
2013-10-10 |
2015-11-18 |
ダイキン工業株式会社 |
空気調和機
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015057692A1
(en)
|
2013-10-14 |
2015-04-23 |
The Johns Hopkins University |
Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
|
|
US10406246B2
(en)
|
2013-10-17 |
2019-09-10 |
Deutsches Kresbsforschungszentrum |
Double-labeled probe for molecular imaging and use thereof
|
|
CN105792855A
(zh)
|
2013-10-18 |
2016-07-20 |
分子制药洞察公司 |
使用spect/ct分析进行癌症分期的方法
|
|
WO2015057250A1
(en)
|
2013-10-18 |
2015-04-23 |
Psma Development Company, Llc |
Combination therapies with psma ligand conjugates
|
|
MY194484A
(en)
*
|
2013-10-18 |
2022-11-30 |
Deutsches Krebsforsch |
Labeled Inhibitors of Prostate Specific Membrane Antigen (PSMA), Their use as Imaging Agents and Pharmaceutical Agents for the Treatment of Prostate Cancer
|
|
MX2016006219A
(es)
|
2013-11-14 |
2016-10-28 |
Endocyte Inc |
Compuestos para tomografia por emision de positrones.
|
|
ITAN20130219A1
(it)
|
2013-11-21 |
2015-05-22 |
Gianluca Valentini |
Farmaco anti-cancro, comprendente un radioisotopo del rame
|
|
AR098523A1
(es)
|
2013-11-25 |
2016-06-01 |
Oxford Biotherapeutics Ltd |
Anticuerpos dirigidos contra matriptasa y composiciones relacionadas
|
|
US9346846B1
(en)
|
2013-12-02 |
2016-05-24 |
Yale University |
Anti-cancer compounds and methods for treating cancer
|
|
EP3082928A1
(en)
|
2013-12-18 |
2016-10-26 |
Koninklijke Philips N.V. |
System and method for enhancing sleep slow wave activity based on cardiac characteristics or respiratory characteristics
|
|
WO2015143029A1
(en)
|
2014-03-18 |
2015-09-24 |
The Johns Hopkins University |
Psma-based molecular-genetic reporter system
|
|
ES2743482T3
(es)
|
2014-05-06 |
2020-02-19 |
Univ Johns Hopkins |
Inhibidores de PSMA marcados con metal/radiometal para obtención de imágenes dirigidas a PSMA y radioterapia
|
|
EP2944635B1
(en)
|
2014-05-15 |
2018-11-28 |
Council of Scientific & Industrial Research |
Pyrazole linked benzimidazole conjugates and a process for preparation thereof
|
|
US9814759B2
(en)
|
2014-07-02 |
2017-11-14 |
Cheer Global Ltd. |
Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
|
|
WO2016022809A2
(en)
|
2014-08-06 |
2016-02-11 |
The Johns Hopkins University |
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (psma) inhibitors
|
|
ES2908411T3
(es)
|
2014-08-06 |
2022-04-29 |
Univ Johns Hopkins |
Profármacos del inhibidor del antígeno de membrana específico de la próstata (PSMA)
|
|
EP2993171A1
(en)
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18F-labeled PSMA-specific PET-tracers
|
|
EP3183236B1
(en)
|
2014-08-24 |
2022-04-20 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften |
Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
|
|
CA2959336A1
(en)
|
2014-08-25 |
2016-03-03 |
The Johns Hopkins University |
Methods and compositions related to prostate cancer therapeutics
|
|
AU2015315465B2
(en)
|
2014-09-08 |
2019-08-29 |
Molecular Insight Pharmaceuticals, Inc. |
Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
|
|
WO2016062370A1
(en)
|
2014-10-20 |
2016-04-28 |
Deutsches Krebsforschungszentrum |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
WO2016065142A2
(en)
|
2014-10-22 |
2016-04-28 |
The Johns Hopkins University |
New scaffolds and multifunctional intermediates for imaging psma and cancer therapy
|
|
ES2832802T3
(es)
|
2014-11-21 |
2021-06-11 |
Univ Maryland |
Sistemas de administración dirigida del particulado específico de una estructura
|
|
KR101698654B1
(ko)
|
2014-12-24 |
2017-01-20 |
포항공과대학교 산학협력단 |
En2에 특이적으로 결합하는 dna 압타머 및 이의 용도
|
|
WO2016115415A1
(en)
|
2015-01-16 |
2016-07-21 |
The Johns Hopkins University |
Albumin-proaerolysin prodrugs
|
|
US20180148480A1
(en)
|
2015-01-16 |
2018-05-31 |
The Johns Hopkins University |
Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapy
|
|
HK1250731A1
(zh)
|
2015-04-13 |
2019-01-11 |
艾杜罗生物科技公司 |
用於治疗癌症的免疫原性融合蛋白
|
|
WO2016168595A1
(en)
|
2015-04-17 |
2016-10-20 |
Barrett David Maxwell |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
|
US9808538B2
(en)
|
2015-09-09 |
2017-11-07 |
On Target Laboratories, LLC |
PSMA-targeted NIR dyes and their uses
|
|
KR101639599B1
(ko)
|
2015-11-09 |
2016-07-14 |
서울대학교산학협력단 |
펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물
|
|
FR3043970B1
(fr)
|
2015-11-25 |
2019-06-21 |
Medtech Sa |
Systeme mecanique de stabilisation au sol pour vehicules a roulettes
|
|
US10688200B2
(en)
|
2015-12-31 |
2020-06-23 |
Five Eleven Pharma Inc. |
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
|
|
WO2018049132A1
(en)
|
2016-09-09 |
2018-03-15 |
On Target Laboratories, LLC |
Psma-targeted nir dyes and their uses
|
|
AU2018250609B2
(en)
|
2017-04-11 |
2024-05-09 |
Adarga, Llc |
Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapy
|
|
MX2020006112A
(es)
|
2017-12-13 |
2020-08-24 |
Sciencons AS |
Complejo que comprende un compuesto orientado a psma vinculado a un radionucleido de plomo o torio.
|
|
IL276653B2
(en)
|
2018-02-22 |
2024-11-01 |
Us Health |
Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
|
|
US11548947B2
(en)
|
2018-06-21 |
2023-01-10 |
Regeneron Pharmaceuticals, Inc. |
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
|